Precision Biomarker for Parkinson’s and Lewy Body Dementia Found

AI Briefing

• – DOPA decarboxylase identified as biomarker for Parkinson's and Lewy body dementia.
• – Study provides reliable way to distinguish from Alzheimer's disease.
• – Misdiagnosis reduced by using this biomarker.